BURINEX 5 mg, tablet 30 tablets
Active ingredients: BUMÉTANIDE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Tablet30 tabletsorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- BURINEX 5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- film(s) thermosoudé(s) aluminium de 30 comprimé(s)
- Marketing authorisation holder
- KARO PHARMA (SUEDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Aug 1998
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67563415CIP73452139CIP133400934521393Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUMÉTANIDEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.